PACAP (6-27) (human, ovine, rat)
PACAP (6-27) (human, ovine, rat) is a PACAP receptor antagonist that blocks the canine adrenal catecholamine response to exogenous vasoactive intestinal peptide (VIP) . PACAP (6-27) (human, ovine, rat) has the potential to study cardiovascular and neurological diseases[1].
Product Specifications
CAS Number
[136134-68-4]
Product Name Alternative
Pituitary adenylate cyclase-activating peptide (6-27)
UNSPSC
12352209
Target
Adenylate Cyclase
Type
Peptides
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/pacap-6-27-human-ovine-rat.html
Purity
98.89
Solubility
DMSO : ≥ 100 mg/mL
Smiles
[Phe-Thr-Asp-Ser-Tyr-Ser-Arg-Tyr-Arg-Lys-Gln-Met-Ala-Val-Lys-Lys-Tyr-Leu-Ala-Ala-Val-Leu-NH2]
Molecular Formula
C121H193N33O31S
Molecular Weight
2638.09
References & Citations
[1]Gaspo R, et al. Canine adrenal catecholamine response to VIP is blocked by PACAP- (6-27) in vivo. Am J Physiol. 1997 May;272 (5 Pt 2) :R1606-12.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Brucella canis Cell cycle response regulator CtrA (ctrA)
Recombinant Brucella canis Cell cycle response regulator CtrA (ctrA)
Recombinant Brucella canis Cell cycle response regulator CtrA (ctrA)
Recombinant Brucella canis Cell cycle response regulator CtrA (ctrA)
Recombinant Brucella canis Cell cycle response regulator CtrA (ctrA)
